Can conventional magnetic resonance imaging at presentation predict chemoresistance in osteosarcoma?
CONCLUSIONS: Findings on baseline MRI could help predicting chemoresistant osteosarcoma with tumour size being the strongest predictor.ADVANCES IN KNOWLEDGE: Osteosarcomas with large size, large cross-sectional diameter, large area of necrosis, presence of intra-articular extension, and extensive peritumoural soft tissue oedema were most likely to have a poor response to neoadjuvant chemotherapy.PMID:38308035 | DOI:10.1093/bjr/tqad047
Source: The British Journal of Radiology - Category: Radiology Authors: Thanat Kanthawang Wanat Wudhikulprapan Phichayut Phinyo Jongkolnee Settakorn Dumnoensun Pruksakorn Thomas M Link Nuttaya Pattamapaspong Source Type: research
More News: Bone Cancers | Brain | Chemotherapy | MRI Scan | Neoadjuvant Chemotherapy Therapy | Neoadjuvant Therapy | Neurology | Orthopaedics | Osteosarcoma | Radiology | UK Health